News

Stay connected – Follow our latest updates and meet our team!

May 23, 2023

Mabqi will be attending at the Convention BIO US

May 22, 2023

Are you planning on attending #AIS2023?

October 14, 2022

Mabqi makes a donation for the French Red Cross

February 8, 2022

Mabqi won the « Prix de l’innovation & international » at Les Inn’Ovations 2022

November 23, 2021

Meet us at the Antibody Engineering and Therapeutics Conference in San Diego – Dec 12-16 2021

April 27, 2021

Meet us during PEGS Boston – May 11-13, 2021

March 9, 2021

Pierre Martineau will speak at Festival of Biologics (Mar 29th – Apr 1st)

March 2, 2021

iMab Labs is now Mabqi

« Previous Page1 Page2 Page3 Page4 Page5 Next »

Mabqi is a biotechnology company focused on the discovery and development of fully human antibodies. Leveraging an innovative platform, we specialize in uncovering monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), pH-sensitive antibodies, and various other immunotherapy formats.

Contact Us

Legal notice

-

Privacy policy